Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 12, 2026, 8:20 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1153–1176 of 13,937 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Control Trial Clear all

Conditions: Fibroid Uterus, Fibroid Tumor, Leiomyoma, Fibromyoma, Leiomyoma, Uterine
Interventions: Simvastatin 40mg, Placebo 40 mg; Drug
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years to 55 Years · Female only
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2026
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Atopic Asthma
Interventions: Oral Silymarin, Oral Silymarin, maintenance dose, Placebo; Drug
Lead sponsor: Vanderbilt University; Other
Eligibility: 18 Years to 75 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Bronchiolitis
Interventions: Epinephrine, albuterol (salbutamol); Drug
Lead sponsor: Kern Medical Center; Other
Eligibility: Up to 18 Months
Enrollment: 600 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2006
U.S. locations: 1
States / cities: Bakersfield, California

Conditions: Enterocolitis, Necrotizing, Congenital Heart Disease
Interventions: Bowel Ultrasound; Device
Lead sponsor: Children's Mercy Hospital Kansas City; Other
Eligibility: Up to 6 Months
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Kansas City, Missouri

Conditions: Dermatitis, Atopic
Interventions: LY3454738, Placebo; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 128 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2021
U.S. locations: 19
States / cities: Anniston, Alabama • North Little Rock, Arkansas • Rogers, Arkansas + 16 more

Conditions: Alcohol Use Disorder
Interventions: PST-APPLE Watch group, Education-only control group; Behavioral
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years to 25 Years
Enrollment: 26 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Upper Tract Urothelial Carcinomas, Urothelial Bladder Cancer
Interventions: Infigratinib, Placebo; Drug
Lead sponsor: QED Therapeutics, a BridgeBio company; Industry
Eligibility: 18 Years and older
Enrollment: 39 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 47
States / cities: Tucson, Arizona • Duarte, California • Loma Linda, California + 39 more

Conditions: Dementia, Alzheimer Disease
Interventions: SMARRT Intervention, Health Education Intervention; Behavioral
Lead sponsor: Kaiser Permanente; Other
Eligibility: 70 Years to 89 Years
Enrollment: 172 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2022
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Physical Inactivity
Interventions: PA Education plus human and planetary health information, PA Education plus Our Voice citizen science; Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 66 Years to 105 Years · Female only
Enrollment: 232 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Stanford, California

Conditions: Idiopathic Pulmonary Fibrosis
Interventions: BI 1015550, Placebo; Drug
Lead sponsor: Boehringer Ingelheim; Industry
Eligibility: 40 Years and older
Enrollment: 1,177 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 56
States / cities: Birmingham, Alabama • Los Angeles, California • Sacramento, California + 45 more

Conditions: Postural; Defect
Interventions: Education for Behavior Modification, Corrective Exercise Program; Behavioral
Lead sponsor: Liberty University; Other
Eligibility: 18 Years to 29 Years
Enrollment: 79 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021
U.S. locations: 1
States / cities: Lynchburg, Virginia

Conditions: Premature Birth
Interventions: Oral Feed, Usual care; Dietary Supplement
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 32 Weeks and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Abortion Late, Pain
Interventions: Local anesthetic for tenaculum placement, Sham, Paracervical Block, Dilator Placement, Post-procedural assessment, Preprocedural pain control; Procedure · Behavioral · Drug
Lead sponsor: University of California, San Diego; Other
Eligibility: 18 Years and older · Female only
Enrollment: 14 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015
U.S. locations: 2
States / cities: San Diego, California

Conditions: Heart Failure, Cardiac Failure, Congestive Heart Failure, Heart Failure, Left-sided
Interventions: HeartAssist 5® VAD System, Control VAD; Device
Lead sponsor: ReliantHeart Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2018
U.S. locations: 14
States / cities: San Francisco, California • Stanford, California • Coral Gables, Florida + 8 more

Conditions: Chronic Kidney Disease (CKD) Stage 5, Kidney Dysfunction Requiring Dialysis (KDRD), Dialysis Dependency
Interventions: Twice-weekly hemodialysis with incremental crossover to thrice-weekly schedule, Thrice-Weekly Hemodialysis; Other
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 252 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 8
States / cities: Long Beach, California • West Los Angeles, California • West Haven, Connecticut + 5 more

Conditions: Persistent Tic Disorders, Tourette Disorder
Interventions: Comprehensive Behavioral Intervention for Tics - Enhanced (CBIT-E); Behavioral
Lead sponsor: Marquette University; Other
Eligibility: 9 Years to 17 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Spasticity
Interventions: Tizanidine, Placebo, Moxifloxacin; Drug
Lead sponsor: Acorda Therapeutics; Industry
Eligibility: 18 Years to 45 Years
Enrollment: 136 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Cardiovascular Risk Factor
Interventions: Digital message (text + image); Behavioral
Lead sponsor: Penn State University; Other
Eligibility: 18 Years to 29 Years
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022
U.S. locations: 1
States / cities: University Park, Pennsylvania

Conditions: Menthol Cigarettes, Smoking Behavior, Cigarette Use
Interventions: Message Exposure via Discrete Choice Experiment; Behavioral
Lead sponsor: Georgia State University; Other
Eligibility: 21 Years and older
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 2
States / cities: Santa Barbara, California • Atlanta, Georgia

Conditions: Whole Blood Donation and Leukoreduction
Interventions: Hemanext Red Blood Cell Processing System; Device
Lead sponsor: Hemanext; Industry
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2019
U.S. locations: 3
States / cities: Cincinnati, Ohio • Norfolk, Virginia • Milwaukee, Wisconsin

Conditions: Recurrent Urinary Tract Infection, Postmenopause, Postmenopausal Syndrome, Postmenopausal Symptoms, Menopause
Interventions: Prasterone, Placebo; Drug
Lead sponsor: Olivia Cardenas-Trowers, M.D.; Other
Eligibility: 18 Years and older · Female only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Louisville, Kentucky

Conditions: Asthma, Asthma in Children
Interventions: SMART@Home; Behavioral
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: 12 Years to 18 Years
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Pediatric Cancer
Interventions: Promoting Resilience in Stress Management; Behavioral
Lead sponsor: Seattle Children's Hospital; Other
Eligibility: 18 Years and older
Enrollment: 107 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2020
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Venous Distension Reflex, Blood Pressure
Interventions: Wrist-to-elbow (W-E) occlusion, ketorolac tromethamine, saline control; Other · Drug
Lead sponsor: Milton S. Hershey Medical Center; Other
Eligibility: 21 Years to 35 Years
Enrollment: 18 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2027
U.S. locations: 1
States / cities: Hershey, Pennsylvania

Search by objective public record fields.

Effects of Simvastatin on Uterine Leiomyoma Size

Randomized Controlled Trial of Silymarin in Asthma

Trial of Epinephrine and Albuterol in Bronchiolitis

Utility of Bowel Ultrasound in Diagnosing Necrotizing Eneterocolitis in Congenital Heart Disease

A Study of LY3454738 in Healthy Participants and Participants With Atopic Dermatitis

Pilot Trial to Evaluate PROblem Solving Therapy and APPLE Watch for College Students

Oral Infigratinib for the Adjuvant Treatment of Subjects With Invasive Urothelial Carcinoma With Susceptible FGFR3 Genetic Alterations

Systematic Multi-domain Alzheimer's Risk Reduction Trial

Testing Multi-Level Remote Physical Activity Interventions in a National Sample of Older Women: The WHISH EnCore Trial

A Study to Find Out Whether BI 1015550 Improves Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF)

Effects of Postural Education or Corrective Exercise on Forward Head Posture

Preterm Functional Early Enteral Development (FEED) Trial on Respiratory Support

Paracervical Block for Pain Control With Osmotic Dilator Placement

Clinical Trial to Evaluate the the ReliantHeart HeartAssist 5® VAD System in Patients Awaiting Heart Transplantation

Incremental Hemodialysis for Veterans in the First Year of Dialysis (IncHVets)

Online-Delivered Comprehensive Behavioral Intervention for Tics-Enhanced (CBIT-E)

A Study to Define the ECG Effects of Tizanidine Compared to Placebo and the Positive Control, Moxifloxacin, in Healthy Men and Women Using a Blinded ECG Evaluator: A Thorough ECG Trial

Precision Assignment of Intervention Messages to Promote Physical Activity - Precision AIM

DoubleTake: Effect of Message Exposure Via a Discrete Choice Experiment With Eye-Tracking on Quit Attempts Among Adults Who Smoke Menthol Cigarettes

Clinical Investigation to Evaluate the Hemanext® Oxygen Reduction System - Pivotal Trial

Clinical Trial on the Preventive Effect of Intravaginal Prasterone on Recurrent Urinary Tract Infections in Postmenopausal Women

SMART@Home Feasibility Trial

PRISM for Parents of Children With Cancer Promoting Resilience in Stress Management (PRISM) Intervention for Parents of Children With Cancer

Autonomic Control of the Circulation and VDR